Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-FR | Version v4-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-11-18 | 2020-11-17 |
Drug Identification Number | 02014068 | 02014068 |
Brand name | CLINIMIX E | CLINIMIX E |
Common or Proper name | CLINIMIX E | CLINIMIX E |
Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
Ingredients | TRYPTOPHAN L-PROLINE L-TYROSINE POTASSIUM PHOSPHATE DIBASIC SODIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM ACETATE DEXTROSE L-LEUCINE HYDROCHLORIDE L-PHENYLALANINE HYDROCHLORIDE L-LYSINE HYDROCHLORIDE METHIONINE L-ALANINE GLYCINE L-ARGININE L-ISOLEUCINE L-VALINE HISTIDINE L-THREONINE | TRYPTOPHAN L-PROLINE L-TYROSINE POTASSIUM PHOSPHATE DIBASIC SODIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM ACETATE DEXTROSE L-LEUCINE HYDROCHLORIDE L-PHENYLALANINE HYDROCHLORIDE L-LYSINE HYDROCHLORIDE METHIONINE L-ALANINE GLYCINE L-ARGININE L-ISOLEUCINE L-VALINE HISTIDINE L-THREONINE |
Strength(s) | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000mL (JB6763) | 500mL (JB6763) |
ATC code | B05BA | B05BA |
ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | 2021-04-16 | 2021-04-16 |
Actual discontinuation date | ||
Remaining supply date | 2021-04-16 | 2021-04-16 |
Discontinuation status | To be discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | Please refer to customer communication dated June 22, 2020 for a complete list of products being discontinued and CLINIMIX products remaining in the market. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information. For ordering support of any of our products, please contact Baxter Customer Service at 1-888-719-9955. | Please refer to customer communication dated June 22, 2020 for a complete list of products being discontinued and CLINIMIX products remaining in the market. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information. For ordering support of any of our products, please contact Baxter Customer Service at 1-888-719-9955. |
Health Canada comments |